U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Elevated urine mevalonic acid level

MedGen UID:
1712812
Concept ID:
C5397655
Finding
Synonyms: Elevated urine mevalonate; Elevated urine mevalonate levels; Elevated urine mevalonic acid; Mevalonate aciduria
 
HPO: HP:0032638

Definition

An abnormally increased amount of mevanolate in the urine. Mevanolate is that hydroxy monocarboxylic acid anion that is the conjugate base of mevalonic acid. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVElevated urine mevalonic acid level

Conditions with this feature

Hyperimmunoglobulin D with periodic fever
MedGen UID:
140768
Concept ID:
C0398691
Disease or Syndrome
Mevalonate kinase deficiency is a condition characterized by recurrent episodes of fever, which typically begin during infancy. Each episode of fever lasts about 3 to 6 days, and the frequency of the episodes varies among affected individuals. In childhood the fevers seem to be more frequent, occurring as often as 25 times a year, but as the individual gets older the episodes occur less often.\n\nMevalonate kinase deficiency has additional signs and symptoms, and the severity depends on the type of the condition. There are two types of mevalonate kinase deficiency: a less severe type called hyperimmunoglobulinemia D syndrome (HIDS) and a more severe type called mevalonic aciduria (MVA).\n\nPeople with MVA have signs and symptoms of the condition at all times, not just during episodes of fever. Affected children have developmental delay, problems with movement and balance (ataxia), recurrent seizures (epilepsy), progressive problems with vision, and failure to gain weight and grow at the expected rate (failure to thrive). Individuals with MVA typically have an unusually small, elongated head. In childhood or adolescence, affected individuals may develop eye problems such as inflammation of the eye (uveitis), a blue tint in the white part of the eye (blue sclera), an eye disorder called retinitis pigmentosa that causes vision loss, or clouding of the lens of the eye (cataracts). Affected adults may have short stature and may develop muscle weakness (myopathy) later in life. During fever episodes, people with MVA may have an enlarged liver and spleen (hepatosplenomegaly), lymphadenopathy, abdominal pain, diarrhea, and skin rashes. Children with MVA who are severely affected with multiple problems may live only into early childhood; mildly affected individuals may have a normal life expectancy.\n\nDuring episodes of fever, people with HIDS typically have enlargement of the lymph nodes (lymphadenopathy), abdominal pain, joint pain, diarrhea, skin rashes, and headache. Occasionally they will have painful sores called aphthous ulcers around their mouth. In females, these may also occur around the vagina. Rarely, people with HIDS develop a buildup of protein deposits (amyloidosis) in the kidneys that can lead to kidney failure. Fever episodes in individuals with HIDS can be triggered by vaccinations, surgery, injury, or stress. Most people with HIDS have abnormally high levels of immune system proteins called immunoglobulin D (IgD) and immunoglobulin A (IgA) in the blood. It is unclear why some people with HIDS have high levels of IgD and IgA and some do not. Elevated levels of these immunoglobulins do not appear to cause any signs or symptoms. Individuals with HIDS do not have any signs and symptoms of the condition between fever episodes and typically have a normal life expectancy.
Mevalonic aciduria
MedGen UID:
368373
Concept ID:
C1959626
Disease or Syndrome
Mevalonic aciduria (MEVA), the first recognized defect in the biosynthesis of cholesterol and isoprenoids, is a consequence of a deficiency of mevalonate kinase (ATP:mevalonate 5-phosphotransferase; EC 2.7.1.36). Mevalonic acid accumulates because of failure of conversion to 5-phosphomevalonic acid, which is catalyzed by mevalonate kinase. Mevalonic acid is synthesized from 3-hydroxy-3-methylglutaryl-CoA, a reaction catalyzed by HMG-CoA reductase (142910). Mevalonic aciduria is characterized by dysmorphology, psychomotor retardation, progressive cerebellar ataxia, and recurrent febrile crises, usually manifesting in early infancy, accompanied by hepatosplenomegaly, lymphadenopathy, arthralgia, and skin rash. The febrile crises are similar to those observed in hyperimmunoglobulinemia D and to periodic fever syndrome (HIDS; 260920), which is also caused by mutation in the MVK gene (summary by Prietsch et al., 2003).

Recent clinical studies

Etiology

Yıldız Ç, Gezgin Yıldırım D, Inci A, Tümer L, Cengiz Ergin FB, Sunar Yayla ENS, Esmeray Şenol P, Karaçayır N, Eğritaş Gürkan Ö, Okur I, Ezgü FS, Bakkaloğlu SA
Joint Bone Spine 2023 Jan;90(1):105490. Epub 2022 Nov 18 doi: 10.1016/j.jbspin.2022.105490. PMID: 36410683
Siemiatkowska AM, van den Born LI, van Hagen PM, Stoffels M, Neveling K, Henkes A, Kipping-Geertsema M, Hoefsloot LH, Hoyng CB, Simon A, den Hollander AI, Cremers FPM, Collin RWJ
Ophthalmology 2013 Dec;120(12):2697-2705. Epub 2013 Sep 29 doi: 10.1016/j.ophtha.2013.07.052. PMID: 24084495
Haas D, Hoffmann GF
Orphanet J Rare Dis 2006 Apr 26;1:13. doi: 10.1186/1750-1172-1-13. PMID: 16722536Free PMC Article
Prietsch V, Mayatepek E, Krastel H, Haas D, Zundel D, Waterham HR, Wanders RJ, Gibson KM, Hoffmann GF
Pediatrics 2003 Feb;111(2):258-61. doi: 10.1542/peds.111.2.258. PMID: 12563048
Hoffmann G, Gibson KM, Brandt IK, Bader PI, Wappner RS, Sweetman L
N Engl J Med 1986 Jun 19;314(25):1610-4. doi: 10.1056/NEJM198606193142504. PMID: 3012338

Diagnosis

Yıldız Ç, Gezgin Yıldırım D, Inci A, Tümer L, Cengiz Ergin FB, Sunar Yayla ENS, Esmeray Şenol P, Karaçayır N, Eğritaş Gürkan Ö, Okur I, Ezgü FS, Bakkaloğlu SA
Joint Bone Spine 2023 Jan;90(1):105490. Epub 2022 Nov 18 doi: 10.1016/j.jbspin.2022.105490. PMID: 36410683
Siemiatkowska AM, van den Born LI, van Hagen PM, Stoffels M, Neveling K, Henkes A, Kipping-Geertsema M, Hoefsloot LH, Hoyng CB, Simon A, den Hollander AI, Cremers FPM, Collin RWJ
Ophthalmology 2013 Dec;120(12):2697-2705. Epub 2013 Sep 29 doi: 10.1016/j.ophtha.2013.07.052. PMID: 24084495
Kovacs L, Hlavatá A, Baldovič M, Paulovicova E, Dallos T, Fehérvízyová Z, Kadasi L
Neuro Endocrinol Lett 2010;31(6):743-6. PMID: 21196927
Haas D, Hoffmann GF
Orphanet J Rare Dis 2006 Apr 26;1:13. doi: 10.1186/1750-1172-1-13. PMID: 16722536Free PMC Article
Hoffmann G, Gibson KM, Brandt IK, Bader PI, Wappner RS, Sweetman L
N Engl J Med 1986 Jun 19;314(25):1610-4. doi: 10.1056/NEJM198606193142504. PMID: 3012338

Therapy

Haas D, Hoffmann GF
Orphanet J Rare Dis 2006 Apr 26;1:13. doi: 10.1186/1750-1172-1-13. PMID: 16722536Free PMC Article
Raal FJ, Pappu AS, Illingworth DR, Pilcher GJ, Marais AD, Firth JC, Kotze MJ, Heinonen TM, Black DM
Atherosclerosis 2000 Jun;150(2):421-8. doi: 10.1016/s0021-9150(99)00435-9. PMID: 10856535
Cobb MM, Salen G, Tint GS
J Am Coll Nutr 1997 Dec;16(6):605-13. PMID: 9430090
Jones PJ, Pappu AS, Hatcher L, Li ZC, Illingworth DR, Connor WE
Arterioscler Thromb Vasc Biol 1996 Oct;16(10):1222-8. doi: 10.1161/01.atv.16.10.1222. PMID: 8857917

Prognosis

Raal FJ, Pappu AS, Illingworth DR, Pilcher GJ, Marais AD, Firth JC, Kotze MJ, Heinonen TM, Black DM
Atherosclerosis 2000 Jun;150(2):421-8. doi: 10.1016/s0021-9150(99)00435-9. PMID: 10856535

Clinical prediction guides

Siemiatkowska AM, van den Born LI, van Hagen PM, Stoffels M, Neveling K, Henkes A, Kipping-Geertsema M, Hoefsloot LH, Hoyng CB, Simon A, den Hollander AI, Cremers FPM, Collin RWJ
Ophthalmology 2013 Dec;120(12):2697-2705. Epub 2013 Sep 29 doi: 10.1016/j.ophtha.2013.07.052. PMID: 24084495
Williams S, Gregory A, Hogarth P, Hayflick SJ, Gillingham MB
Mol Genet Metab 2013 Nov;110(3):336-41. Epub 2013 Jul 1 doi: 10.1016/j.ymgme.2013.06.017. PMID: 23891537Free PMC Article
Prietsch V, Mayatepek E, Krastel H, Haas D, Zundel D, Waterham HR, Wanders RJ, Gibson KM, Hoffmann GF
Pediatrics 2003 Feb;111(2):258-61. doi: 10.1542/peds.111.2.258. PMID: 12563048
Hoffmann G, Gibson KM, Brandt IK, Bader PI, Wappner RS, Sweetman L
N Engl J Med 1986 Jun 19;314(25):1610-4. doi: 10.1056/NEJM198606193142504. PMID: 3012338

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...